Diabetic peripheral neuropathy is a common long-term complication of diabetes that occurs when constant high blood glucose levels damage the patient’s nerves. It commonly causes pain, tingling sensation, and numbness in the toes and feet. Since they are numb, patients often do not notice minor cuts and blisters, which could then get infected increasing patient’s risk of gangrene and leg amputations.
The risk of developing diabetic peripheral neuropathy is higher for patients who suffer from type 2 diabetes. Thus, they are advised to undergo screening and regular annual tests. However, for patients who already experience the symptoms of the condition, it is best that they consult diabetes and foot care specialists to receive appropriate treatment.
This, however, entails additional healthcare costs on top of their existing treatment costs for diabetes. Thus, patients will benefit greatly by heading to Southeast Asia, where the costs of healthcare are some of the lowest in the world. Patients don’t have to worry though, as this low price does not necessarily translate to subpar care and service. In fact, Southeast Asia’s roster of world-class, Joint Commission International (JCI)-accredited hospitals is steadily growing, as more and more medical facilities in the region rise up to meet international standards in healthcare.
Patients can thus simply look for hospitals that bear the prestigious Joint Commission International accreditation. JCI commends hospitals that offer advanced treatment procedures, excellent nursing care, and cutting edge medical technology. The region’s top destinations, namely Singapore, Thailand, and Malaysia, are also known for providing prompt medical treatment with almost no waiting times.
For the highest level of medical care and management for type II diabetes, patients’ best choices in the region include Bangkok Hospital Medical Center, Bumrungrad International, and Vejthani Hospital. All three Bangkok-based hospitals are certified by JCI for their respective diabetes type II programme.